(August 15, 2023, 8:18 AM EDT) -- TEL AVIV, Israel — Drugmaker Teva Pharmaceutical Industries Ltd. told stockholders that it and acute care hospitals have reached an agreement in principle on the financial terms of a $126 million, 18-year settlement plus up to $49 million worth of the company’s naloxone overdose reversal drug for up to seven years....